Search Results - "Mirto, Gayle"

Point-of-care and standard laboratory coagulation testing during cardiovascular surgery : Balancing reliability and timeliness by FITCH, J. C. K, MIRTO, G. P, GEARY, K. L. B, BYRNE, D. W, HINES, R. L

“…The use of point-of-care technology has increased faster than efforts to validate its effectiveness compared to standard laboratory testing modalities. To…”
Get full text

Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer by Burtness, Barbara, Thomas, Laurie, Sipples, Rebecca, McGurk, Meghan, Salikooti, Saritha, Christoforou, Maryanne, Mirto, Gayle, Salem, Ronald, Sosa, Julieann, Kloss, Robert, Rahman, Zia, Chung, Gina, Lacy, Jill, Murren, John R

“…Docetaxel and irinotecan have activity in pancreatic cancer. The combination of docetaxel and irinotecan is attractive because of preclinical evidence of…”
Get full text

Heparin management test versus activated coagulation time during cardiovascular surgery: Correlation with anti-Xa activity by Fitch, Jane C.K., Geary, Kristin L.B., Mirto, Gayle P., Byrne, Daniel W., Hines, Roberta L.

“…Objective: To compare the abilities of the heparin management test (HMT) and the activated coagulation time (ACT) to provide a measurement of heparin effect in…”
Get full text